Security
VHAQ.WS · Viveon Health Acquisition Corp.
VHAQ.WSNYSEWarrantHistorical · closed Oct 4, 2024CIK 1823857Updated Sep 26, 2026
VHAQ.WS price & chart
Historical security
This listing closed Oct 4, 2024. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | 2,489,829Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | 157,140Source | — |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts PayableUSD | 179,076Source | 47,720Source | — |
| Deferred Income Tax Expense (Benefit)USD | -39,259Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -1,753,388Source | -2,082,334Source | — |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 150,191,819Source | — | — |
| Cash flows from financing activities: | |||
| Payments for Repurchase of Common StockUSD | 152,451,819Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -148,813,819Source | -619,387Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 19,847Source | — | 3,096,956Source |
| Additional Financial Items | |||
| Share-based Payment Arrangement, ExpenseUSD | — | 157,140Source | — |
| Amortization of Debt Issuance CostsUSD | 392,642Source | — | — |
| Income Tax Expense (Benefit)USD | 61,310Source | — | — |
| Investment Income, InterestUSD | — | 20,329Source | — |
| Net Income (Loss) Attributable to ParentUSD | -605,294Source | 2,489,829Source | — |
| Nonoperating Income (Expense)USD | 1,945,823Source | 6,595,616Source | — |
| Operating Costs and ExpensesUSD | 756,386Source | 1,050,016Source | — |
| Payments of Financing CostsUSD | — | 25,749Source | — |
| Payments to Acquire InvestmentsUSD | 2,260,000Source | — | — |
| Unrealized Gain (Loss) on DerivativesUSD | -3,209,183Source | — | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 |
|---|---|---|
| Operating Income (Loss)USD | -2,489,807Source | -4,105,787Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -543,984Source | — |
| Income Tax Expense (Benefit)USD | 61,310Source | — |
| Net Income (Loss) Attributable to ParentUSD | -605,294Source | 2,489,829Source |
| Earnings Per Share, BasicUSD per share | -0.05Source | — |
| Earnings Per Share, DilutedUSD per share | -0.05Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 12,224,223Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 12,224,223Source | — |
| Additional Financial Items | ||
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 2Source | — |
| Costs and ExpensesUSD | 500,000Source | — |
| Interest ExpenseUSD | 3,645,777Source | — |
| Interest Income, OtherUSD | — | 147Source |
| Investment Income, InterestUSD | — | 20,329Source |
| Nonoperating Income (Expense)USD | 1,945,823Source | 6,595,616Source |
| Operating Costs and ExpensesUSD | 756,386Source | 1,050,016Source |